Who has invested in BioTroy Therapeutics?

No investors are named on the public record for BioTroy Therapeutics yet.

BioTroy Therapeutics Funding: $21M Raised, Series A (2025)

BioTroy Therapeutics funding overview

BioTroy Therapeutics is based in Shanghai, China. BioTroy Therapeutics has raised $21M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in June 2025. The round record for BioTroy Therapeutics runs through 2025; nothing later has been disclosed.

BioTroy Therapeutics at a glance

Total raised: $21M
Latest round: Series A
Latest round date: June 2025
Headquarters: Shanghai, China

Frequently asked about BioTroy Therapeutics funding

How much has BioTroy Therapeutics raised?: BioTroy Therapeutics has raised $21M in total disclosed funding across the rounds on record.
Who has invested in BioTroy Therapeutics?: No investors are named on the public record for BioTroy Therapeutics yet.
What was the latest BioTroy Therapeutics funding round?: The most recent disclosed round is a Series A, announced in June 2025.
Where is BioTroy Therapeutics based?: BioTroy Therapeutics is based in Shanghai, China.
When did BioTroy Therapeutics last raise?: The last disclosed BioTroy Therapeutics round closed in June 2025 at Series A.

Round data for BioTroy Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Shanghai and backer lists below.

BioTroy Therapeutics Funding: $21M Raised, Series A (2025)

BioTroy Therapeutics funding overview

BioTroy Therapeutics at a glance

Frequently asked about BioTroy Therapeutics funding

Companies related to BioTroy Therapeutics (18)

Browse related funding lists (5)